José Gil Martínez-rekin lankidetzan egindako argitalpenak (32)

2022

  1. Interval cytoredutive surgery and HIPEC in advanced ovarian cancer with small-bowel disease: results and reflections

    Clinical and Translational Oncology, Vol. 24, Núm. 8, pp. 1542-1548

2021

  1. Acute renal disease in patients with ovarian peritoneal carcinomatosis treated with cytoreduction and HIPEC: the influence of surgery and the cytostatic agent used

    Langenbeck's Archives of Surgery, Vol. 406, Núm. 7, pp. 2449-2456

  2. Urinary and fecal incontinence in patients with advanced ovarian cancer treated with CRS + HIPEC

    Surgical Oncology, Vol. 36, pp. 115-119

2020

  1. Identifying the incidence of respiratory complications following diaphragmatic cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy

    Clinical and Translational Oncology, Vol. 22, Núm. 6, pp. 852-859

  2. Intraperitoneal hyperthermic chemotherapy after cytoreduction in patients with peritoneal metastases from endometrial cancer. The next frontier?

    Surgical Oncology, Vol. 33, pp. 19-23

  3. Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies

    Hernia, Vol. 24, Núm. 2, pp. 257-263

  4. Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): multicenter study of the Spanish Group of Peritoneal Cancer Surgery (GECOP)

    Clinical and Translational Oncology, Vol. 22, Núm. 1, pp. 130-136

  5. Tako-tsubo syndrome after intraperitoneal hyperthermic chemotherapy (HIPEC) with cisplatin: an unusual complication of cytoreductive surgery plus HIPEC

    Clinical and Experimental Metastasis

2019

  1. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP)

    Annals of Surgical Oncology, Vol. 26, Núm. 8, pp. 2615-2621

  2. Effect of Paclitaxel-based Hyperthermic Intraperitoneal Chemotherapy (HIPEC) on colonic anastomosis in a rat model

    Clinical and Translational Oncology, Vol. 21, Núm. 4, pp. 505-511

  3. Peritoneal Surface Disease Severity Score (PSDSS), AGO-score and TIAN model in patients with platinum-sensitive recurrent ovarian cancer treated by cytoreductive surgery plus HIPEC

    Clinical and Experimental Metastasis, Vol. 36, Núm. 5, pp. 433-439

2018

  1. Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey

    European Journal of Surgical Oncology, Vol. 44, Núm. 2, pp. 228-236

  2. ¿Qué hacer cuando se descubre un seudomixoma peritoneal durante la reparación de una hernia de pared abdominal?

    Cirugia Espanola, Vol. 96, Núm. 2, pp. 120-121

2017

  1. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified?

    Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1388-1392

2016

  1. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in elderly patients. A systematic literature review

    Surgical Oncology, Vol. 25, Núm. 4, pp. 378-384

  2. Effectiveness and failures of a fast track protocol after cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy in patients with peritoneal surface malignancies

    Surgical Oncology, Vol. 25, Núm. 4, pp. 349-354

  3. Hyperthermic intraperitoneal chemotherapy with paclitaxel or cisplatin in patients with stage III-C/IV ovarian cancer. is there any difference?

    Surgical Oncology, Vol. 25, Núm. 3, pp. 164-170

  4. Morbidity and mortality outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients aged 75 years and over: Spanish group of peritoneal cancer surgery (GECOP) multicenter study

    Surgical Oncology, Vol. 25, Núm. 2, pp. 111-116

  5. Use of 18F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue

    European Journal of Radiology, Vol. 85, Núm. 10, pp. 1824-1828

2015

  1. Alterations in hemostasis during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis

    Cirugia Espanola, Vol. 93, Núm. 8, pp. 496-501